Price target
66.330.000.00%
The 9 analysts offering 1 year price forecasts for ARCT have a max estimate of — and a min estimate of —.
Analyst rating
Based on 11 analysts giving stock ratings to ARCT in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
ARCT EPS for the last quarter is −1.11 USD despite the estimation of −0.55 USD. In the next quarter EPS is expected to reach −1.18 USD. Track more of Arcturus Therapeutics Holdings Inc. financials and stay on top of what is up with the company.
In the next quarter Arcturus Therapeutics Holdings Inc. revenue is expected to reach 23.35 M USD. Check out Arcturus Therapeutics Holdings Inc. revenue and earnings and make informed decisions.
According to analysts, ARCT price target is 66.33 USD with a max estimate of 140.00 USD and a min estimate of 44.00 USD. Check if this forecast comes true in a year, meanwhile watch Arcturus Therapeutics Holdings Inc. stock price chart and keep track of the current situation with ARCT news and stock market news.
We've gathered opinions of 11 analysts rating ARCT stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.